Ultime notizie per Covalon Technologies (OTC:CVALF) Azioni

Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.

Press Releases

Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Events

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard

CVALF

TSXV:COV

COVALON TECHS LTD by Covalon Technologies Ltd.

Covalon Technologies

Comments

Covalon Technologies

Notizie

Ultime notizie per Covalon Technologies (OTC:CVALF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO